Back to search

Article

Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy. Implications for Radiopharmaceutical Repurposing (Beyond Oncology)

2025-08-04

Abstract excerpt

The integration of nanotechnology into drug repurposing strategies is redefining the development landscape for diagnostic, therapeutic, and theranostic agents. Originally based on radiopharmaceuticals, many of these nanoplatforms evolve into multifunctional systems by incorporating additional imaging modalities (e.g., MRI, fluorescence) or non-radioactive therapies (e.g., photodynamic therapy, chemotherapy). These...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
99e86eb4-ca92-55cc-becc-a3f9a5905c7e
DOI
10.20944/preprints202508.0202.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Strategic Objectives of Nanotechnology-Driven Repurposing in Radiopharmacy. Implications for Radiopharmaceutical Repurposing (Beyond Oncology)DOI 10.20944/preprints202508.0202.v1
Biomedical Applications of Targeted Drug Delivery, Nanotheranostic and Nuclear MedicineSemantic proximity
Molecular Theranostics: A Primer for the Imaging ProfessionalSemantic proximity
Advances in Cancer Treatment through Nanotheranostics and Emerging TherapiesSemantic proximity
Nuclear-based labeling of cellular immunotherapies: a simple protocol for preclinical useSemantic proximity
Nuclear medicine and molecular imaging advances in the 21st centurySemantic proximity
Redox-Responsive Theranostic Nanoplatforms in Oncology: Linking Tumor Microenvironment Biology, Proteasome Targeting, and Clinical TranslationSemantic proximity
GBM radiosensitizers: dead in the water…or just the beginning?Semantic proximity
Magnetic resonance imaging-based biodistribution of theranostic AGuIX nanoparticles in the NANORAD 2 clinical trial for brain metastasesSemantic proximity
Theranostics of Bone Metastases: The Role and Prospects of Bisphosphonate RadiopharmaceuticalsSemantic proximity
Nanoparticle-based drug delivery systems: What can they really do in vivo?Semantic proximity
Convergence of nanotechnology and cancer prevention: are we there yet?Semantic proximity
Personalized Drug Delivery with Smart Nanotechnology and AI InnovationsSemantic proximity
Select a neighboring publication to make it the new centre.